Social determinants of health (SDOH) play a critical role in health outcomes, but standardized SDOH data collection is lacking. How is NCQA driving standardization through national SDOH quality measures?

Featuring: Rachel Harrington, PhD, AVP of health equity sciences, NCQA

Adrianna Nava, PhD, MPA, applied research scientist, NCQA

In today’s episode, we’ll cover…

and more!

To learn more about SDOH data collection, check out our Health IT and EHR site and our Patient Engagement site.

To watch video clips from our podcast, subscribe to our YouTube channel, @HealthcareStrategies.

References

Charting new territory: the early lessons in integrating social determinant of health (SDOH) measures into practice  https://academic.oup.com/healthaffairsscholar/article/2/11/qxae138/7900537 

How Regenstrief and HL7 are driving SDOH data standards https://www.techtarget.com/searchhealthit/feature/How-Regenstrief-and-HL7-are-driving-SDOH-data-standards https://www.techtarget.com/searchhealthit/feature/How-Regenstrief-and-HL7-are-driving-SDOH-data-standards  

Advocating for SDOH data standards to support health equity https://www.techtarget.com/searchhealthit/podcast/Advocating-for-SDOH-data-standards-to-support-health-equity 

AI has officially transcended buzzword status, with healthcare continuously diving deeper into its uses and applications. But as technology continues to proliferate healthcare, experts eye questions about the effects on patient experience and the industry's overall push for more patient-centered care. In this episode, we explore those questions and discuss how healthcare can embrace AI as a leading clinical decision support tool without losing site of its patient-centered goals.

Featuring: Prashila Dullabh, vice president and senior fellow in Health Sciences at NORC at the University of Chicago

In today's episode, we'll cover…

…and more!

To learn more about patient-centered care and healthcare's embrace of AI, check out our Xtelligent sites: Patient Engagement, Healthtech Analytics and Health IT.

To watch video clips from our podcast, subscribe to our YouTube channel, @HealthcareStrategies.

References:

Enhancing Patient Engagement through Shared Decision-Making https://www.techtarget.com/patientengagement/feature/Enhancing-Patient-Engagement-through-Shared-Decision-Making 

What Are the Top Challenges of Clinical Decision Support Tools?

Sexual orientation and gender identity (SOGI) data is key for improving health outcomes among sexual

Featuring: Carey Candrian, PhD, associate professor of medicine at the University of Colorado School of

In today's episode, we'll cover:

And more!

To learn more about AI in healthcare, check out our site, Healthtech Analytics.

To watch video clips from our podcast, subscribe to our YouTube channel, @Healthcare Strategies.

References

2025 promises to be an interesting year in healthcare with many possibilities, challenges and unknowns. A few of our editorial staff members got together to discuss the trends we will be watching in the new year, from telehealth flexibilities to artificial intelligence guardrails, and from employers' cost-cutting efforts to the future of reproductive health.

Featuring: Shania Kennedy, assistant editor of Healthtech Analytics at Xtelligent

Veronica Salib, associate editor of Pharma Life Sciences at Xtelligent Healthcare

Anuja Vaidya, senior editor of Virtual Healthcare and special events lead at Xtelligent Healthcare

Kelsey Waddill, multimedia manager and managing editor of Healthcare Payers at Xtelligent Healthcare

In today’s episode, we’ll cover…

...and more!

To learn more about 2025 healthcare industry predictions, check out our Xtelligent sites: Healthtech Analytics, Healthcare Payers, Pharma Life Sciences, and Virtual Healthcare.

Thank you to Dr. Sanjula Jain, Melissa Knuth, and Dr. Stephanie Page who spoke with us earlier in the season and whose insights we included in this episode.

GLP-1 general impact overview https://www.techtarget.com/pharmalifesciences/feature/Anticipating-the-healthcare-reach-of-GLP-1-receptor-agonists

CDC unintended pregnancy data https://www.cdc.gov/reproductive-health/hcp/unintended-pregnancy/index.html#:~:text=Overview,2010%20to%2041.6%25%20in%202019

Vasectomy data from the University of Florida Health https://ufhealth.org/stories/2022/what-to-know-before-getting-a-vasectomy

Planned Parenthood data on vasectomy reversals https://www.plannedparenthood.org/blog/are-vasectomies-reversible#

HR managers see value in GLP-1 coverage https://ir.accolade.com/news-releases/news-release-details/glp-1-coverage-employer-plans-could-nearly-double-2024

Employer coverage rates of GLP-1s for weight loss https://www.ifebp.org/resources---news/survey-reports/glp-1-drugs--2024-pulse-survey-report-(u.s.-corporate-data)

Exploring generative AI in healthcare https://www.techtarget.com/healthtechanalytics/feature/Exploring-generative-artificial-intelligence-in-healthcare

Introducing the role of Chief Analytics Officer https://www.techtarget.com/healthtechanalytics/answer/Exploring-the-Role-of-Cleveland-Clinics-First-Chief-Analytics-Officer

Telehealth volumes data from Trilliant Health https://www.techtarget.com/virtualhealthcare/answer/Examining-the-limitations-of-the-current-telehealth-market

Leveraging RPM at home for cancer care https://www.techtarget.com/virtualhealthcare/feature/Leveraging-RPM-to-Enable-At-Home-Care-for-High-Risk-Cancer-Patients

Vendor uses wearables to assess impact of GLP-1s on Parkinson's disease https://www.statnews.com/2024/12/10/glp-1-parkinsons-health-tech-startup-koneksa-digital-measures/ 

As the reproductive health landscape continues to evolve, access to contraception and prescriptions for contraception are increasingly critical tools for preventing unplanned pregnancies. In some states, pharmacists at retail pharmacies can play a critical role in contraceptive access by providing counseling and prescriptions for some birth control methods.

Featuring: Dr. Mollie Scott, a pharmacist, the regional associate dean of the University of North Carolina Eshelman School of Pharmacy, and Chair of the Department of Pharmacotherapy at Mountain Area Health Education Center.

In today’s episode, we’ll cover

And more!

To watch video clips from our podcast, subscribe to our YouTube channel, @HealthcareStrategies.

Note: The Healthcare Strategies team will be on break for 12/30/24, but make sure to tune in for our first episode of the new year (publishing 1/6/25) where we cover major trends for 2025!

Resources:

Clinical Pharmacists Are a Major Contributor to Quality Patient Care https://www.techtarget.com/pharmalifesciences/feature/Clinical-Pharmacists-Are-a-Major-Contributor-to-Quality-Patient-Care

Understanding the widespread impacts of pharmacy deserts https://www.techtarget.com/pharmalifesciences/answer/Understanding-the-widespread-impacts-of-pharmacy-deserts

Limited Access to Female Contraceptives: A Public Health Crisis https://www.techtarget.com/pharmalifesciences/feature/Limited-Access-to-Female-Contraceptives-A-Public-Health-Crisis

Assessing the Expected Impacts of OTC Hormonal Birth Control Pills https://www.techtarget.com/pharmalifesciences/feature/Assessing-the-Expected-Impacts-of-OTC-Hormonal-Birth-Control-Pills 

The future of telehealth policy remains uncertain, with pandemic-era regulatory flexibilities set to expire by the end of the year, barring Congressional action. What is holding Congress back from extending or solidifying these flexibilities, and will those concerns influence telehealth legislation in 2025?

Featuring: Darryl Roberts, Vice President of Health Informatics at RELI Group

In today's episode, we'll cover…

References:

Spending Bill to Extend Telehealth, Hospital-at-Home Waivers for 2 Years (https://www.techtarget.com/virtualhealthcare/news/366596488/Spending-Bill-to-Extend-Telehealth-Hospital-at-Home-Waivers-for-2-Years)

HHS: How the End of the PHE Will Impact Telehealth Flexibilities (https://www.techtarget.com/virtualhealthcare/news/366596867/HHS-How-the-End-of-the-PHE-Will-Impact-Telehealth-Flexibilities)

What the NJ Lawsuit Adds to Out-of-State Telehealth, Licensure Debates (https://www.techtarget.com/virtualhealthcare/answer/What-the-NJ-Lawsuit-Adds-to-Out-of-State-Telehealth-Licensure-Debates)

What the House subcommittee hearing tells us about telehealth’s future (https://www.techtarget.com/virtualhealthcare/feature/What-the-House-subcommittee-hearing-tells-us-about-telehealths-future)

To learn more about telehealth policy, check out our site, Xtelligent Virtual Healthcare.

To watch video clips from our podcast, subscribe to our YouTube channel, @HealthcareStrategies.

GLP-1 (glucagon-like peptide 1) medications are revolutionizing weight loss and diabetes care, but behind the hype lies a growing web of regulatory gaps, telehealth expansion and online pharmacy risks. This episode unpacks the opportunities -- and dangers -- shaping the future of these life-changing drugs.

Featuring: Scott Roth, Chief Executive Officer, LegitScript

Gerard Olsen, Director of Research, LegitScript

In today’s episode, we'll cover…

To learn more about GLP-1 medications from all angles, check out our Pharma Life Sciences, Patient Engagement and Healthcare Payers sites.

To watch video clips from the conversation, subscribe to our YouTube channel, @HealthcareStrategies.

References:

Metabolic bariatric surgery in the GLP-1 era (https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825349)

Risks of online semaglutide without prescription (https://www.techtarget.com/pharmalifesciences/news/366609735/Study-uncovers-risks-of-buying-semaglutide-online)

FDA updates on GLP-1 compounding policies (https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize)

Staffing shortages and rising operational costs are daunting challenges for community health centers, which are vital for serving underserved populations. How can the right technology investments help community health centers overcome these obstacles?

Featuring: Abby Sears, president and CEO of OCHIN

Jeff Lowrance, CEO of OSIS

In today’s episode, we’ll cover…

and more!

To learn more about health IT, check out Health IT and EHR site.

To watch video clips from our podcast, subscribe to our YouTube channel, @HealthcareStrategies.

References:

Finances stymie patient data sharing, interoperability at FQHCs (https://www.techtarget.com/searchhealthit/news/366578868/Finances-Stymie-Patient-Data-Sharing-Interoperability-at-FQHCs)

Community health center access up by 1 million patients (https://www.techtarget.com/patientengagement/news/366599934/Community-health-center-access-up-by-1-million-patients)

Community Health Centers’ Progress and Challenges in Meeting Patients’ Essential Primary Care Needs (https://www.commonwealthfund.org/publications/issue-briefs/2024/aug/community-health-centers-meeting-primary-care-needs-2024-FQHC-survey)

As many patients decide whether to take glucagon-like peptide 1 agonists (or GLP-1s), providers face various new patient engagement challenges. What patient engagement strategies can providers pursue to achieve shared decision-making, even when their patients decide to take GLP-1 compounds? In this episode, we hear one local dietitian share her experience guiding patients through the decision to take GLP-1s and we'll also touch base with one of our senior staff members to get a more comprehensive perspective on patient engagement trends in this area.

Featuring: Kate, a local dietitian in the Boston area

Sara Heath, executive editor at Xtelligent Healthcare

In this episode, we'll cover

and more!

References

Patient education tips for GLP-1, weight loss drug treatment (https://techtarget.com/patientengagement/feature/Patient-education-tips-for-GLP-1-weight-loss-drug-treatment)

Is care management missing from the GLP-1 drug discourse? (https://www.techtarget.com/patientengagement/feature/Is-care-management-missing-from-the-GLP-1-drug-discourse)

To learn more about patient engagement, check out our Patient Engagement site.

To learn more about GLP-1s, visit our Pharma Life Sciences site.

And to watch video clips from the conversation, subscribe to our YouTube channel, @HealthcareStrategies.

GLP-1 drugs, like Ozempic, Wegovy, and Zepbound, have gained attention for their significant health impacts and anti-obesity effects. However, there continues to be a lot of unknowns surrounding these medications, their long-term impacts, and access.

Featuring: Dr. Lydia Alexander, an obesity medicine specialist, lifestyle specialist, president of the Obesity Medicine Association (OMA), Chief Medical Officer at Enara, and a medical chef.

In today’s episode, we’ll cover

• The significant progress made in GLP-1 research, care delivery, and insurance coverage

And more!

To watch video clips from our podcast, subscribe to our YouTube channel, @Healthcare Strategies

Resources:

• Are compounded “DIY” peptides the answer to the GLP-1 shortage?